Big Sioux Wealth Management’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-200
Closed -$31.3K – 290
2026
Q2
$31.3K Hold
200
– – 0.02% 176
2026
Q1
$30.6K Hold
200
– – 0.02% 171
2025
Q4
$27.6K Buy
+200
New +$26.2K 0.02% 171

Other funds holding NVS

Big Sioux Wealth Management's NVS Position: Q3 2026 in Review

Big Sioux Wealth Management sold out of Novartis (NVS) in Q3 2026, closing a stake of 200 shares — an estimated $31.3K sold.

Big Sioux Wealth Management first reported a position in NVS in Q4 2025 and held it in 3 quarters. The position peaked at $31.3K in Q2 2026. 1,560 funds tracked by Wall St. Rank hold NVS as of Q3 2026.

  • Big Sioux Wealth Management reported no remaining Novartis position as of Q3 2026 after selling out during the quarter.
  • Big Sioux Wealth Management sold 200 Novartis shares in Q3 2026, an estimated $31.3K.
  • Big Sioux Wealth Management first reported a position in Novartis in Q4 2025 and held it in 3 quarters.
  • Big Sioux Wealth Management's Novartis position peaked at $31.3K in Q2 2026.
  • 1,560 funds tracked by Wall St. Rank held Novartis as of Q3 2026.

Based on Big Sioux Wealth Management's 13F filing for Q3 2026, filed 19 Nov 2026.